Insider trades
Dirk Thye, CEO of Quince Therapeutics QNCX, has filed 4 purchases and 0 sales on the open market. The latest trade was on 01/23.
Dirk Thye
CEO and CMO
- Company
- Quince Therapeutics QNCX
- First filing
- 23/02/02
- Trades
- 16 trades
- Buys / sales
- 4 / 0
- 12-month net buying
- No record
- Last trade
- 01/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
QNCX | Open-market buy | 24/08/29–24/08/30 | 24/09/03 | 154,500 sh2 trades | $0.69avg. | $107,375 | +22.4% |
| Open-market buy | 23/08/10 | 23/08/11 | 88,000 sh | $1.26 | $110,880 | +24.4% | |
| Open-market buy | 23/08/08 | 23/08/09 | 80,000 sh | $1.24 | $99,200 | +28.5% |